Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
30.48
-0.06 (-0.20%)
At close: Aug 1, 2025, 4:00 PM
30.50
+0.02 (0.07%)
After-hours: Aug 1, 2025, 4:10 PM EDT

Xenon Pharmaceuticals Stock Forecast

Stock Price Forecast

The 11 analysts that cover Xenon Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $54.82, which forecasts a 79.86% increase in the stock price over the next year. The lowest target is $47 and the highest is $67.

Price Target: $54.82 (+79.86%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$47$54.82$55$67
Change+54.20%+79.86%+80.45%+119.82%
* Price targets were last updated on May 14, 2025.

Analyst Ratings

The average analyst rating for Xenon Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy334555
Buy444666
Hold000000
Sell000000
Strong Sell000000
Total778111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Evercore ISI Group
Evercore ISI Group
Buy
Initiates
$55
BuyInitiates$55+80.45%May 14, 2025
Wells Fargo
Wells Fargo
Buy
Maintains
$50$47
BuyMaintains$50$47+54.20%May 13, 2025
RBC Capital
RBC Capital
Buy
Maintains
$58$55
BuyMaintains$58$55+80.45%May 13, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$53
Strong BuyReiterates$53+73.88%May 13, 2025
Needham
Needham
Strong Buy
Maintains
$60$55
Strong BuyMaintains$60$55+80.45%May 13, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
7.14M
Revenue Next Year
25.26M
from 7.14M
Increased by 253.71%
EPS This Year
-4.10
from -3.01
EPS Next Year
-4.48
from -4.10
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
32.17M18.44M9.43M--7.14M25.26M97.30M
Revenue Growth
371.02%-42.68%-48.83%---253.71%285.27%
EPS
-0.80-1.77-2.06-2.73-3.01-4.10-4.48-4.48
EPS Growth
--------
Forward PE
--------
No. Analysts
-----212118
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High8.4M210.0M295.0M
Avg7.1M25.3M97.3M
Lown/an/a18.6M

Revenue Growth

Revenue Growth20252026202720282029
High-
2,841.2%
1,068.0%
Avg-
253.7%
285.3%
Low--
-26.3%

EPS Forecast

EPS20252026202720282029
High-3.60-2.15-1.12
Avg-4.10-4.48-4.48
Low-4.39-5.63-5.71

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.